## Abstract 1‐(2′‐deoxy‐2′‐fluoro‐__β__‐D‐arabinofuranosyl)‐[__methyl__‐^11^C]thymine ([^11^C]FMAU) [^11^C]‐**1** was synthesised __via__ a palladium‐mediated Stille coupling reaction of 1‐(2′‐deoxy‐2′‐fluoro‐__β__‐D‐arabinofuranosyl)‐5‐(trimethylstannyl)uracil **2** with [^11^C]methyl iodide in a
Synthesis of 3-[(2S)-azetidin-2-ylmethoxy]-5-[11C]-methylpyridine, an analogue of A-85380, via a Stille coupling
✍ Scribed by Farhad Karimi; Bengt Långström
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 123 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.569
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
3‐[(2S)‐azetidin‐2‐ylmethoxy]‐5‐[^11^C]‐methylpyridine (5d), which might be a novel ligand for nicotinic receptors, was synthesized via coupling [^11^C]iodomethane with tert‐butyl (2S)‐2‐({[5‐(trimethylstannyl)pyridin‐3‐yl]oxy}methyl) azetidine‐1‐carboxylate (4) at 80°C for 5 min with tri‐o‐tolylphosphine‐bound, unsaturated palladium(0), followed by deprotection using trifluoroacetic acid (TFA). The previous problem (solid‐phase extraction before injection on semi‐preparative LC) with automation of Stille coupling reactions has been overcome. In a typical experiment, 0.46 GBq of 5d was obtained from 5.2 GBq of [^11^C]iodomethane. The decay‐corrected radiochemical yield was 39% (based on the quantity [^11^C]iodomethane trapped). The synthesis time was 43 min from end of radionuclide production. During a production condition using 36 μAh of proton beam irradiation, a specific radioactivity of 50 GBq/μmol of the final product was obtained in biological buffer. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract The synthesis of a series of epoxy 5‐phenylmorphans is being explored in order to determine the conformational requirements of the phenolic ring in a phenylmorphan molecule that may be needed both for binding to a specific opioid receptor and for exhibiting opioid agonist or antagonist
## Abstract ^14^C‐Labelled (S)‐(+)‐6‐(2‐chlorophenyl)‐3‐cyclopropanecarbonyl‐8,11‐dimethyl‐2,3,4,5‐ tetrahydro‐8H‐pyrido[4′,3′:4,5]thieno[3,2‐f][1,2,4]triazolo[4,3‐a][1,4] diazepine (^14^C‐E6123), a platelet activating factor receptor antagonist for studying the pharmacokinetic profile of E6123, wa
## Abstract The Pictet‐Spengler reaction is performed as a one‐pot procedure by condensing thienylethylamine (I) with carbonyl compounds (II), followed by treatment of the in situ formed imines with acetic‐formic anhydride (III) to produce a formyliminium ion, which upon treatment with TFA cyclizes